Castle Biosciences CSTL Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's operating cash flow?
- Castle Biosciences (CSTL) reported operating cash flow of -$22.13M in Q1 2026.
- How has Castle Biosciences's operating cash flow changed year-over-year?
- Castle Biosciences's operating cash flow decreased by 266.6% year-over-year, from -$6.04M to -$22.13M.
- What is the long-term trend for Castle Biosciences's operating cash flow?
- Over 3 years (2021 to 2025), Castle Biosciences's operating cash flow has grown at a 50.2% compound annual growth rate (CAGR), from -$18.98M to $64.35M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.